A. Benson

发表

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.

E. Winer, R. Wahl, S. Edge, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Clinical Practice Guidelines in Oncology: colon cancer.

M. Choti, J. Fleshman, C. Willett, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

M. Choti, C. Willett, Yi-Jen Chen, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.

Denys T. Lau, S. Weitzman, D. Dorr, 2007, Archives of internal medicine.

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Yun Yen, Steven A Curley, Edgar Ben-Josef, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Ahmed Kamel, Howard S Hochster, Christopher G Willett, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase 3 Trial of 177Lu‐Dotatate for Midgut Neuroendocrine Tumors

J. Berlin, E. Mittra, E. Van Cutsem, 2017, The New England journal of medicine.

Oltipraz: A laboratory and clinical review

A. Benson, A. Benson, 1993, Journal of cellular biochemistry. Supplement.

Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.

P. Catalano, P. Johnston, A. Benson, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

Daniel G Haller, P. Catalano, J. Berlin, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.

A. Rademaker, A. Benson, M. Mulcahy, 2016, The oncologist.

Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.

D. Neuberg, A. Benson, D. Haller, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

J Ricke, T Maughan, W. Oyen, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

P J Catalano, P. Catalano, A. Benson, 2001, The New England journal of medicine.

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

A. Khorana, M. Shah, A. Benson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rectal cancer clinical practice guidelines in oncology.

M. Choti, T. Yeatman, C. Willett, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.

P. Catalano, J. Berlin, A. Benson, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.

M. Somerfield, A. Benson, D. Pfister, 2004, The New England journal of medicine.

Discussion: Diagnostic issues in early-stage disease

Heidi Nelson, Lee S. Rosen, Kenneth J. Chang, 2007 .

Pancreatic Adenocarcinoma, Version 1.2019.

E. Nakakura, A. Koong, A. Benson, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

A. Benson, E. Vokes, S. Kornblau, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of cancer treatment-related diarrhea. Issues and therapeutic strategies.

A. Benson, E. Vokes, S. Kornblau, 2000, Journal of pain and symptom management.

J. Ajani, A. Benson, E. Vokes, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.

R. Labianca, K. Haustermans, E. Van Cutsem, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results.

R. Schilsky, A. Benson, R. Goldberg, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neuroendocrine tumors, version 1.2015.

J. Berlin, T. Giordano, J. Vauthey, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature

A. Benson, M. Talamonti, R. Vogelzang, 1998, Cancer.

A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma

A. Benson, J. Hecht, Z. Wainberg, 2017, The oncologist.

Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus.

D. Neuberg, R. Ginsberg, T. Pajak, 1999, International journal of radiation oncology, biology, physics.

NCCN Practice Guidelines for Colorectal Cancer.

M. Choti, T. Yeatman, N. Petrelli, 2000, Oncology.

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

A. Benson, S. Kircher, R. Lentz, 2019, Journal of surgical oncology.

M. Somerfield, N. Petrelli, T. Smith, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.

J. Manola, M. Hanna, M. Oken, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5‐fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204

A. Benson, Steven J. Cohen, E. Sigurdson, 2013, Cancer.

NCCN GUIDELINES ® INSIGHTS CE Pancreatic Adenocarcinoma , Version 1 . 2019 Featured Updates to the NCCN Guidelines

E. Nakakura, A. Benson, M. Tempero, 2019 .

Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types.

A. Benson, Suneel D. Kamath, S. Kircher, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Accomplishments in 2007 in the management of localized gastric cancer.

A. Benson, C. V. D. van de Velde, 2008, Gastrointestinal cancer research : GCR.

NCCN Task Force Report : Positron Emission Tomography ( PET ) / Computed Tomography ( CT ) Scanning in Cancer

R. Coleman, R. Advani, A. Zelenetz, 2007 .

JNCCN NCCN Task Force Report : PET / CT Scanning in Cancer

R. Coleman, R. Advani, A. Zelenetz, 2007 .

Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate.

A. Benson, Elizabeth Brown, 2008, American health & drug benefits.

New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancers: Cooperative Group Strategies for Assessing Optimal Approaches in Early-Stage Disease

A. Benson, 2007, Clinical Cancer Research.

Perspectives on the Use of Tumor Markers

A. Benson, M. Mulcahy, 2004 .

Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Rese

A. Benson, Steven J. Cohen, E. Sigurdson, 2015, The oncologist.

Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.

A. Benson, N. Kemeny, H. Hochster, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up

A. Rademaker, T. Ryan, A. Benson, 2019, The oncologist.

Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.

A. Benson, J. Kugler, J. Robertson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant chemotherapy of stage III colon cancer.

A. Benson, 2005, Seminars in oncology.

Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors

J. Berlin, A. Benson, L. Saltz, 2020, Clinical Cancer Research.

Phase I study of oral irinotecan as a single-agent and given sequentially with capecitabine

J. Berlin, A. Benson, A. Tan, 2012, Investigational New Drugs.

Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer

M. Somerfield, A. Benson, D. Haller, 2004 .

Optimal use of the combination of irinotecan and 5-fluorouracil.

A. Benson, R. Goldberg, 2003, Seminars in oncology.

Future directions in adjuvant therapy for rectal cancer.

A. Benson, 2002, Oncology.

A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma.

J. Berlin, A. Benson, D. Haller, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200

P. Catalano, A. Benson, S. Alberts, 2005 .

Therapy for advanced colorectal cancer.

A. Benson, 1998, Seminars in oncology.

Factors Associated With Sphincter-Preserving Surgery for Rectal Cancer at National Comprehensive Cancer Network Centers

J. Niland, A. Benson, L. Temple, 2009, Annals of surgery.

Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.

P. Catalano, F. Spitz, A. Benson, 2008, International journal of radiation oncology, biology, physics.

Epidermal growth factor receptor-targeted therapy in colorectal cancer.

A. Benson, P. O'dwyer, 2002, Seminars in oncology.

Local-regional therapy for metastatic liver tumors.

A. Benson, M. Talamonti, C. Tellez, 1998, Cancer treatment and research.

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.

A. Benson, M. Weiser, J. Skibber, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

S. Kalnicki, J. Palefsky, A. Onitilo, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.

A. Benson, S. Reddy, M. Mulcahy, 2016, Clinical colorectal cancer.

Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.

P. Catalano, A. Benson, S. Alberts, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictive Biomarkers and Personalized Medicine Association betweenVEGFSplice IsoformsandProgression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab

P. Catalano, S. Harper, D. Bates, 2012 .

Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer.

B. B. Weitner, A. Rademaker, A. Benson, 2011, International journal of radiation oncology, biology, physics.

Chemotherapy-induced mucositis: focusing on diarrhea.

A. Benson, K. Wisinski, 2007, The journal of supportive oncology.

Strategic planning for patients who present with metastatic colorectal cancer

A. Benson, 2006 .

Response of pancreatic carcinoma to 5-fluorouracil and leucovorin.

A. Benson, D. Grinblatt, 1992, The American journal of medicine.

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

M. Somerfield, E. Van Cutsem, A. Benson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E5202: The GI Intergroup Strategy for Stage II Colon Cancer Patients

A. Benson, 2007 .

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.

Yuman Fong, Jerome Seidenfeld, Michael A Choti, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hurdles to Data Collection in the Oncology Community

A. Benson, M. Farber, J. Peller, 2012 .

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, C. Willett, Yi-Jen Chen, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines.

M. Somerfield, N. Petrelli, T. Smith, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of the accountable care act of 2010 on clinical trial insurance coverage.

A. Benson, S. Kircher, H. Nimeiri, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group

R. Labianca, A. Benson, J. Zalcberg, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trials of cetuximab (CX) plus cisplatin (CDDP), 5-fluorouracil (5-FU) and radiation (RT) in immunocompetent (ECOG 3205) and HIV-positive (AMC045) patients with squamous cell carcinoma of the anal canal (SCAC): Safety and preliminary efficacy results.

P. Catalano, J. Palefsky, A. Benson, 2012 .

Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

S. Severi, D. Metz, J. Berlin, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

90Y-edotreotide for metastatic carcinoid refractory to octreotide.

E. Van Cutsem, A. Benson, A. Grossman, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs): Well-Differentiated NETs of the Distal Colon and Rectum

A. Benson, D. Klimstra, W. Maples, 2010, Pancreas.

Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.

A. Benson, M. Mulcahy, A. Fought, 2019, The oncologist.

Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors.

M. Broder, P. Philip, A. Benson, 2015, World journal of gastroenterology.

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group

E. Montgomery, P. Catalano, A. Benson, 2011, Cancer Chemotherapy and Pharmacology.

Innovating Cancer Care Delivery: the Example of the 4R Oncology Model for Colorectal Cancer Patients

W. Gradishar, A. Benson, J. Trosman, 2019, Current Treatment Options in Oncology.

Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care Delivery.

W. Gradishar, B. Rapkin, I. Gareen, 2016, Journal of oncology practice.

Use of Molecular Assays and Circulating Tumor DNA in Early Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group (GICTEG).

A. Benson, A. Grothey, H. Soares, 2021, The oncologist.

Gefitinib in advanced unresectable hepatocellular carcinoma: Results from the Eastern Cooperative Oncology Group's Study E1203.

A. Benson, P. O'dwyer, J. Kauh, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) Results of Protocol E1293

D. Neuberg, A. Benson, P. O'dwyer, 1996, Medical oncology.

NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer Network.

J. Doroshow, A. Benson, M. Tempero, 1996, Oncology.

Magnitude of progression-free survival (PFS) improvement and treatment (Tx) duration in metastatic colorectal cancer (mCRC) for bevacizumab (BV) in combination with oxaliplatin-containing regimens: An analysis of two phase III studies

P. Catalano, A. Benson, J. Cassidy, 2007 .

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

E. Nakakura, A. Koong, A. Benson, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.

A. Benson, D. Cunningham, J. Bridgewater, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accomplishments in 2008 in the management of curable metastatic colorectal cancer.

A. Benson, G. Folprecht, R. Adam, 2009, Gastrointestinal cancer research : GCR.

Colon cancer, version 3.2014.

James D. Murphy, C. Willett, Yi-Jen Chen, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Examining disparities in colon cancer treatment patterns

A. Benson, D. Bentrem, C. Bennett, 2008 .

Maintenance etidronate in the prevention of malignancy-associated hypercalcemia.

A. Benson, E. Siris, J. Schiller, 1987, Archives of internal medicine.

E4206: AMG 706 and Octreotide in Patients with Low‐Grade Neuroendocrine Tumors

A. Benson, J. Hinshaw, P. Engstrom, 2018, The oncologist.

Neuroendocrine TumorsPractice Guidelines in Oncology

M. Choti, J. Berlin, M. Dwyer, 2012 .

Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients.

A. Benson, R. Carlos, G. Sadigh, 2019, Journal of the American College of Radiology : JACR.

Body mass index (BMI) as a prognostic and predictive factor in stage II/III colon cancer: An analysis of the ACCENT database.

R. Labianca, D. Sargent, A. Benson, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NEUROENDOCRINE TUMORS

J. Olson, D. Ettinger, J. Ajani, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

The effects of bevacizumab on postoperative complications in patients undergoing colorectal and pancreatic cancer resection

A. Rademaker, A. Benson, D. Bentrem, 2010, Journal of surgical oncology.

Neuroendocrine tumors.

M. Choti, J. Berlin, J. Vauthey, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Epidermal growth factor receptor-targeted therapy in colorectal cancer.

A. Benson, P. O'dwyer, 2002, Seminars in oncology.

Hepatobiliary cancers, version 2.2014.

T. Pawlik, J. Vauthey, Y. Yen, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Neuroendocrine tumors.

M. Choti, J. Berlin, M. Dwyer, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Colon cancer: the new chronic disease.

A. Benson, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293).

S. Lipsitz, A. Benson, C. Falkson, 2000, American journal of clinical oncology.

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, C. Willett, Yi-Jen Chen, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer.

A. Rademaker, A. Benson, M. Cobleigh, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatobiliary cancers. Clinical practice guidelines in oncology.

T. Yeatman, C. Earle, M. Sinanan, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

J. Berlin, T. Giordano, M. Heslin, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

2011 update in gastrointestinal cancer therapeutics.

A. Benson, H. Nimeiri, V. Sahai, 2012, Gastrointestinal cancer research : GCR.

A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201

A. Benson, S. Alberts, H. Cárdenes, 2008 .

Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study.

M. Neary, A. Benson, M. Kulke, 2019, The oncologist.

Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study.

M. Neary, A. Benson, M. Kulke, 2019, The oncologist.

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.

Y. Bang, C. Fuchs, E. Van Cutsem, 2020, JAMA oncology.

Bortezomib (B) and doxorubicin (dox) in patients (pts) with hepatocellular cancer (HCC): A phase II trial of the Eastern Cooperative Oncology Group (ECOG 6202) with laboratory correlates

J. Berlin, A. Benson, M. Mulcahy, 2008 .

Impact of bevacizumab dose reduction on clinical outcomes for patients treated on the Eastern Cooperative Oncology Group's Study E3200.

P. Catalano, A. Benson, P. O'dwyer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.

M. Choti, J. Fleshman, C. Willett, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions

A. Benson, J. Galon, F. Sinicrope, 2020, Oncoimmunology.

An evaluation of RAS testing among metastatic colorectal cancer patients in the USA.

A. Benson, L. Sangaré, K. Lowe, 2021, Future oncology.

Advanced gastric cancer: an update and future directions.

A. Benson, 2008, Gastrointestinal cancer research : GCR.

Changes in epidermal growth factor receptor signaling in serum and tumor biopsies obtained from patients with progressive metastatic colorectal cancer (MCRC) treated with gefitinib (ZD1839): an Eastern Cooperative Oncology Group study.

B. LaFleur, J. Berlin, M. Washington, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group

R. Labianca, A. Benson, J. Zalcberg, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Postoperative adjuvant chemotherapy (CTX) use in patients (Pts) with stage II/III rectal cancer treated with neoadjuvant therapy: A National Comprehensive Cancer Network (NCCN) analysis.

J. Niland, A. Benson, M. Weiser, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E4201: Randomized phase II study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with locally advanced, unresectable, pancreatic cancer (LAPC): Quality-of-life (QOL) analysis.

D. Cella, A. Benson, S. Alberts, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anal carcinoma: Clinical practice guidelines in oncology™

M. Choti, J. Fleshman, J. Berlin, 2010 .

Immunoscore to provide prognostic information in low- (T1-3N1) and high-risk (T4 or N2) subsets of stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance).

D. Sargent, A. Benson, J. Galon, 2018 .

Association of immune markers and Immunoscore with survival of stage III colon carcinoma (CC) patients (pts) treated with adjuvant FOLFOX: NCCTG N0147 (Alliance).

D. Sargent, A. Benson, J. Galon, 2017 .

CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer.

A. Benson, R. Goldberg, P. Enzinger, 2010 .

The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.

M. Lacouture, A. Benson, J. Patel, 2006, The journal of supportive oncology.

Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT). The Eastern Cooperative Oncology group (ECOG) results.

S. Lipsitz, A. Benson, A. Einzig, 1995, Investigational new drugs.

Diarrhea and Constipation: Supportive Oncology Management

A. Benson, R. Stein, 2009 .

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).

P. Catalano, A. Benson, James C Yao, 2015 .

Multi-center phase II study of S-1 plus cisplatin in patients with advanced gastric carcinoma (AGC)

J. Ajani, A. Benson, H. Lenz, 2005 .

What level of evidence: the elusive balance in drug development.

A. Benson, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

42 : A Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre and Post Chemoradiation (CRT) 5-FU vs. Gemcitabine (G) for Resected Pancreatic Adenocarcinoma

R. Abrams, C. Willet, A. Benson, 2006 .

Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292).

P. Catalano, A. Benson, M. Talamonti, 2011, International journal of radiation oncology, biology, physics.

Phase III trial of gemcitabine (30-minute infusion) versus gemcitabine (fixed-dose-rate infusion [FDR]) versus gemcitabine + oxaliplatin (GEMOX) in patients with advanced pancreatic cancer (E6201).

J. Berlin, D. Cella, A. Benson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of 5‐fluorouracil, leucovorin, and interferon‐α in the treatment of patients with metastatic or recurrent gastric carcinoma

S. Lipsitz, M. Morrisey, A. Benson, 1999, Cancer.

ZD9331 in combination with topotecan: phase I and II experience

A. Benson, I. Vergote, E. Poplin, 2003, Anti-cancer drugs.

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, James D. Murphy, C. Willett, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Transient neurologic dysfunction following moderate‐dose methotrexate for undifferentiated lymphoma

J. Brown, A. Benson, J. Lesser, 1984, Cancer.

Angiosarcoma of the breast following segmental mastectomy complicated by lymphedema.

A. Benson, J. Benda, A. Al-Jurf, 1987, American journal of clinical pathology.

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

S. Raman, J. Vauthey, A. Benson, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study.

S. Lipsitz, A. Benson, M. Talamonti, 1996, International journal of radiation oncology, biology, physics.

Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122.

D. Neuberg, R. Ginsberg, A. Benson, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intravenous etidronate in the management of malignant hypercalcemia.

A. Benson, A. Paterson, A. Paterson, 1985, Archives of internal medicine.

First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA

A. Benson, M. Broder, A. Benson, 2018, Journal of medical economics.

A phase II study of continuous infusion 5‐fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

A. Benson, M. Tallman, T. Kuzel, 1993, Cancer.

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.

J. Sicklick, J. Vauthey, A. Benson, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.

M. Ratain, A. Benson, R. Mick, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy.

J. Willson, A. Benson, S. Remick, 1989, Cancer research.

Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract (UGIT)

S. Lipsitz, A. Benson, A. Einzig, 1995, Investigational New Drugs.

Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.

S. Lipsitz, J. Kirkwood, A. Benson, 1996, American journal of clinical oncology.

All-trans retinoic acid, low-dose cytosine arabinoside and granulocyte colony-stimulating factor in acute myelogenous leukemia: update of an illinois cancer center phase d pilot study

L. Gordon, A. Benson, M. Tallman, 1996 .

Phase II study of fludarabine phosphate for gastric adenocarcinoma

R. Schilsky, A. Benson, J. Wade, 2004, Investigational New Drugs.

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

E. Nakakura, Jeanne Shen, A. Benson, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Cancer Management Chapter 11: Pancreatic, neuroendocrine GI, and adrenal cancers

A. Benson, A. Sasson, Facp., 2010 .

Treatment of liver metastases in patients with neuroendocrine tumors: A National Comprehensive Cancer Network analysis.

E. Nakakura, M. Choti, M. Bloomston, 2013 .

* Phase I/II Clinical Trials INITIAL RESULTS OF A PHASE II TRIAL OF HIGH DOSE RADIATION THERAPY, 5FLUOROURACIL, AND CISPLATIN FOR PATIENTS WITH ANAL CANCER (E4292): AN EASTERN COOPERATIVE ONCOLOGY GROUP STUDY

S. Lipsitz, A. Benson, M. Talamonti, 1996 .

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial.

E. Van Cutsem, A. Benson, J. Tabernero, 2015, European journal of cancer.

Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma.

A. Benson, E. Mitchell, P. Ritch, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Correlations between leukocyte count and absolute granulocyte count in patients receiving cancer chemotherapy

J. Koeller, A. Benson, D. Tormey, 1985, Cancer.

Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.

Bruce D Minsky, M. Somerfield, N. Petrelli, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.

J. Hecht, A. Benson, A. Shields, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colon cancer clinical practice guidelines in oncology.

M. Choti, T. Yeatman, Yi-Jen Chen, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

J. Meyerhardt, James D. Murphy, C. Willett, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Aggressive intracranial teratocarcinoma with ventriculoperitoneal shunt metastases.

A. Benson, T. Kuzel, L. Cerullo, 1989, The American journal of medicine.

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.

C. Compton, D. Kerr, M. Bertagnolli, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.

J. Manola, S. Arbuck, A. Benson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Practice Guidelines in Oncology TM

M. Choti, J. Fleshman, C. Willett, 2009 .

Localized Colon Cancer, version 3.2013

M. Choti, C. Willett, C. Fuchs, 2013 .

Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

M. Choti, C. Willett, Yi-Jen Chen, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.

J. Meyerhardt, C. Willett, Yi-Jen Chen, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Updates on immunotherapy for colorectal cancer.

A. Benson, M. Mulcahy, A. Kalyan, 2018, Journal of gastrointestinal oncology.

NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.

D. Berry, T. Choueiri, R. Carlson, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

O. W. Lindwasser, J. Zell, M. Diehn, 2020, Nature Reviews Clinical Oncology.

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

J. Meyerhardt, R. Schilsky, M. Bertagnolli, 2017, JAMA.

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.

R. Labianca, D. Kerr, K. Haustermans, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group

J. Berlin, A. Benson, M. Mulcahy, 2014, Investigational New Drugs.

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Ahmed Kamel, Howard S Hochster, Christopher G Willett, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

E. Nakakura, M. Dillhoff, A. Koong, 2017, The Journal of the National Comprehensive Cancer Network.

A Phase II Trial of Perifosine in Locally Advanced, Unresectable, or Metastatic Pancreatic Adenocarcinoma

A. Benson, K. Rowland, E. Mitchell, 2007, American journal of clinical oncology.

Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.

J. Tepper, A. Benson, M. O’connell, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of number of nodes retrieved on outcome in patients with rectal cancer.

C. Compton, J. Tepper, A. Benson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.

Charles R. Thomas, D. Sargent, J. Donohue, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

J. Tepper, A. Benson, M. O’connell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Task Force Report: mTOR inhibition in solid tumors.

P. Febbo, D. Ettinger, R. Figlin, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

W. Willett, J. Meyerhardt, E. Giovannucci, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.

B. LaFleur, J. Berlin, M. Washington, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rectal cancer.

M. Choti, Yi-Jen Chen, C. Fuchs, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

Michael A Choti, Gerard M Doherty, M. Choti, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Advances in Treatment Selection for Patients with Metastatic Colorectal Cancer

A. Benson, B. Schulte, 2021 .

A Blueprint to Advance Colorectal Cancer Immunotherapies

Vanessa M. Hubbard-Lucey, L. Diaz, E. Jaffee, 2017, Cancer Immunology Research.

NCCN Rectal Cancer , Version 2 . 2018 Clinical Practice Guidelines in Oncology

J. Meyerhardt, James D. Murphy, C. Willett, 2018 .

Status of targeted therapies in the adjuvant treatment of colon cancer.

A. Benson, Valerie M Nelson, 2013, Journal of gastrointestinal oncology.

Path toward prognostication and prediction: an evolving matrix.

A. Benson, S. Hamilton, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International adaptations of NCCN Clinical Practice Guidelines in Oncology.

R. Carlson, A. Benson, A. Venook, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR

M. Neary, A. Benson, F. Vekeman, 2017, Journal of medical economics.

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

P. Catalano, J. Berlin, D. Cella, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Young Age and Aggressive Treatment in Colon Cancer.

H. Nelson, A. Benson, Julia R Berian, 2015, JAMA.

NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Christopher Willett, Michael A Choti, Krystyna Kiel, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

A case for more intensive systemic therapy for patients with locally advanced rectal cancer: even in the face of a pathologic complete response.

A. Benson, M. Vergo, 2011, Gastrointestinal cancer research : GCR.

Current Issues in Rectal Cancer Chemotherapy

A. Benson, M. Joseph, 2007, Cancer journal.

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

David Cella, Lynne Wagner, Christopher H Crane, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial

R. Abrams, C. Willett, A. Benson, 2011, Annals of Surgical Oncology.

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

R. Abrams, C. Willett, A. Benson, 2008, JAMA.

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5‐fluorouracil, and cisplatin followed by radiotherapy and 5‐fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

P. Catalano, A. Benson, M. Talamonti, 2010, Journal of surgical oncology.

NCCN clinical practice guidelines in oncology. Anal carcinoma.

M. Choti, J. Fleshman, J. Berlin, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.

E. Nakakura, J. Cameron, J. Berlin, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

E. Nakakura, A. Koong, A. Benson, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Pancreatic adenocarcinoma.

E. Nakakura, J. Cameron, J. Berlin, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology

E. Nakakura, J. Cameron, J. Berlin, 2010 .

Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.

A. Benson, M. Mulcahy, H. Hochster, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

A. Rademaker, E. Perez, W. Gradishar, 2014, Journal of the National Cancer Institute.

C. Tournigand, R. Labianca, J. Ajani, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Targeting Angiogenesis in Colorectal Cancer: Tyrosine Kinase Inhibitors.

A. Benson, S. Kircher, H. Nimeiri, 2016, Cancer journal.

NCCN task force: clinical utility of PET in a variety of tumor types.

R. Coleman, S. Singhal, R. J. Lee, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study.

A. Rademaker, A. Benson, J. Bean, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colon cancer. Clinical practice guidelines in oncology.

A. Benson, L. Saltz, P. Engstrom, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG‐ACRIN Cancer Research Group (E4203)

P. Catalano, A. Benson, J. Grem, 2018, Cancer.

Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial.

R. Abrams, C. Willett, A. Benson, 2012, International journal of radiation oncology, biology, physics.

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.

S. Lipsitz, A. Benson, T. Pisansky, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer

A. Maitra, A. Benson, C. Kumar-Sinha, 2020, Journal for ImmunoTherapy of Cancer.

Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.

A. Benson, M. Morse, H. Hochster, 2019, The oncologist.

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 2.2019: Featured Updates to the NCCN Guidelines

J. Sicklick, J. Vauthey, A. Benson, 2019 .

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial

P. Catalano, A. Benson, P. O'dwyer, 2018, JAMA oncology.

Barriers to the use of personalized medicine in breast cancer.

W. Gradishar, A. Benson, Al B Benson, 2012, Journal of oncology practice.

An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma

A. Benson, A. Behdad, V. Yaghmai, 2018, Case reports in oncological medicine.

Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach

Zhong Zheng, Yun Yen, Chandan Guha, 2016, Pancreas.

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer

P. Catalano, J. Berlin, A. Benson, 2016, American journal of clinical oncology.

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group

E. Montgomery, P. Catalano, Xifeng Wu, 2011, BMC Cancer.

Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer

J. Berlin, A. Benson, 2010, Nature Reviews Clinical Oncology.

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

J. Sicklick, J. Vauthey, A. Benson, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.

Jeffery T. Sloan, D. Sargent, N. Petrelli, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma.

D. Doval, A. Benson, J. Fuloria, 2005, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

Pancreatic AdenocarcinomaPractice Guidelines in Oncology

E. Nakakura, J. Cameron, J. Berlin, 2010 .

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.

R. Abrams, C. Willett, A. Benson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Adam P Dicker, Raymond Lai, John R Mackey, 2009, Gastroenterology.

Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group

A. Benson, J. Dutcher, J. Erban, 2004, Investigational New Drugs.

Epidemiology, disease Progression, and Economic Burden of Colorectal Cancer

A. Benson, Al B Benson, 2007, Journal of managed care pharmacy : JMCP.

Surveillance Strategies after Curative Treatment of Colorectal Cancer

M. Somerfield, A. Benson, D. Pfister, 2004 .

What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.

W. Gradishar, A. Benson, J. Trosman, 2013, Journal of comparative effectiveness research.

Path Toward Prognostication and Prediction: An

A. Benson, R. Lurie, S. Hamilton, 2011 .

Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203.

P. Catalano, A. Benson, P. O'dwyer, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systemic Treatment in Unresectable Metastatic Well-Differentiated Carcinoid Tumors: Consensus Results From a Modified Delphi Process

M. Broder, A. Benson, D. Cherepanov, 2013, Pancreas.

Randomized Phase II Trial of Either Fluorouracil, Parenteral Hydroxyurea, Interferon‐αt‐2a, and Filgrastim or Doxorubicin/Docetaxel in Patients with Advanced Gastric Cancer with Quality‐of‐Life Assessment: Eastern Cooperative Oncology Group Study E6296

P. Catalano, D. Cella, A. Benson, 2002, Cancer journal.

Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205).

E. Montgomery, P. Catalano, A. Jimeno, 2019, The oncologist.

Phase II study of amonafide in gastric adenocarcinoma

R. Schilsky, A. Benson, M. Mullane, 2004, Investigational new drugs.

E2205: A phase II study to measure response rate and toxicity of neoadjuvant chemoradiotherapy (CRT) with oxaliplatin (OX) and infusional 5-fluorouracil (5-FU) plus cetuximab (C) followed by postoperative docetaxel (DT) and C in patients with operable adenocarcinoma of the esophagus.

E. Montgomery, P. Catalano, A. Benson, 2010 .

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.

J. Berlin, P. Philip, A. Benson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).

Yi Wang, J. Oh, A. Benson, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).

P. Catalano, N. Petrelli, J. Sloan, 2019, The oncologist.

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma

A. B. Benson, J. Ajani, A. Benson, 2008, Cancer Chemotherapy and Pharmacology.

Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal Cancer

A. Benson, H. Lenz, J. Marshall, 2008, Clinical Cancer Research.

Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.

A. Rademaker, A. Benson, A. Benson, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thymidylate S ynthase P rotein E xpression i n P rimary Colorectal C ancer: L ack o f C orrelation W ith O utcome a nd Response t o F luorouracil i n M etastatic D isease S ites

P. Catalano, P. Johnston, A. Benson, 2003 .

Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.

A. Rademaker, M. Ratain, A. Benson, 2000, Clinical Cancer Research.

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.

A. Benson, R. Goldberg, P. Enzinger, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

B. Yeh, A. Benson, R. Kelley, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.

A. Benson, M. Weiser, J. Skibber, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Neuroendocrine and adrenal tumors, version 2.2018 featured updates to the nccn guidelines

J. Berlin, T. Giordano, M. Heslin, 2018 .

Dosing patterns for octreotide LAR in neuroendocrine tumor (NET) patients: NCCN NET outcomes database.

M. Choti, M. Bloomston, A. Benson, 2013 .

Prevalence of functional tumors in neuroendocrine carcinoma: An analysis from the NCCN NET database.

E. Nakakura, M. Choti, M. Bloomston, 2012 .

Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.

J. Ajani, A. Benson, H. Lenz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Have the changes in treatment of rectal cancer made a significant difference to our patients?

A. Benson, J. Guillem, B. Minsky, 2011, Oncology.

Outcomes differences for African Americans and Caucasians treated with bevacizumab, FOLFOX4 or the combination in patients with metastatic colorectal cancer (MCRC): Results from the Eastern Cooperative Oncology Group Study E3200

P. Catalano, A. Benson, N. Meropol, 2007 .

Epidemiology of Anal Canal Cancer.

A. Benson, Valerie M Nelson, 2017, Surgical oncology clinics of North America.

Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab

P. Catalano, S. Harper, D. Bates, 2012, Clinical Cancer Research.

Neoadjuvant treatment of rectal cancer: where are we now?

A. Benson, A. Kalyan, Shaina Rozelle, 2016, Gastroenterology report.

Preoperative chemotherapy for locally advanced resectable colon cancer - a new treatment paradigm in colon cancer?

A. Benson, H. Nimeiri, Zheng Zhou, 2013, Annals of translational medicine.

Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia.

A. Benson, O. Kucuk, J. Wade, 2000, American journal of clinical oncology.

Pembrolizumab for the treatment of gastric cancer

A. Benson, Suneel D. Kamath, A. Kalyan, 2018, Expert review of anticancer therapy.

Phase II trial of fludarabine phosphate for adenocarcinoma of the pancreas

A. Benson, C. Shapiro, R. Blough, 1992, Investigational New Drugs.

Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelines

J. Sicklick, J. Vauthey, A. Benson, 2017 .

Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis.

J. Niland, A. Benson, M. Weiser, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

A. Benson, J. Hecht, J. Bendell, 2017, The oncologist.

Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck

A. Benson, E. Vokes, F. Rosen, 1995, Investigational New Drugs.

Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results.

A. Benson, 1998, Oncology.

RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma.

R. Abrams, C. Willett, A. Benson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

Christopher G Willett, R. Abrams, C. Willett, 2012, International journal of radiation oncology, biology, physics.

PHASE III TRIAL OFADJUVANT CHEMOTHERAPYAND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS

R. Abrams, C. Willett, A. Benson, 2011 .

Accomplishments in 2007 in the management of localized pancreatic cancer.

A. Benson, M. Moore, 2008, Gastrointestinal cancer research : GCR.

Adjuvant therapy for pancreatic cancer: one small step forward.

A. Benson, 2007, JAMA.

Meeting the 12 lymph node (LN) benchmark in colon cancer

J. Niland, A. Benson, M. Weiser, 2010, Journal of surgical oncology.

Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial

A. Benson, M. Mulcahy, B. Burtness, 2023, The oncologist.

Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?

Steven Hirschfeld, Jonathan R Nebeker, Kenneth R Carson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines

James D. Murphy, C. Willett, C. Fuchs, 2015 .

Telemedicine in Oncology and Reimbursement Policy During COVID-19 and Beyond.

A. Benson, M. Mulcahy, J. Trosman, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group.

A. Benson, J. Kugler, D. Haller, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia.

A. Benson, H. Lenz, J. Hecht, 2003, Oncology.

Long-term survival outcome of E1201: An Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged esophageal adenocarcinoma.

P. Catalano, A. Benson, L. Kleinberg, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

E1201: An Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/RT or irinotecan/cisplatin/RT in endoscopy with ultrasound (EUS) staged adenocarcinoma of the esophagus

A. Benson, L. Kleinberg, P. Anné, 2007 .

Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design.

P. Catalano, A. Benson, L. Kleinberg, 2016, International journal of radiation oncology, biology, physics.

618PDA PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF SIMTUZUMAB OR PLACEBO IN COMBINATION WITH GEMCITABINE FOR THE FIRST LINE TREATMENT OF PANCREATIC ADENOCARCINOMA.

A. Benson, Z. Wainberg, J. Bendell, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581).

C. Compton, D. Kerr, A. Benson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends in the Treatment of Colorectal Cancer

A. Benson, M. Mulcahy, 2005 .

Personalizing Adjuvant Therapy for Stage II/III Colorectal Cancer.

A. Benson, R. Dienstmann, N. McCleary, 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

39 : RTOG 9704 - Radiotherapy Quality Assurance (QA) Review and Survival

R. Abrams, C. Willett, A. Benson, 2006 .

BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer

A. Benson, J. Bridgewater, C. Van Sant, 2016, Clinical Cancer Research.

Phase I/II trial of combined 131I anti‐CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma

A. Benson, V. Sathiaseelan, M. Groch, 1996, Cancer.

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

D. Ettinger, R. Carlson, A. Benson, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index

D. Cella, S. Yount, A. Benson, 2020, Neuroendocrinology.

Prospective validation of genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) in a racially diverse cohort: Results from ECOG-ACRIN E1Z11.

A. Benson, J. Sparano, C. Loprinzi, 2021 .

A phase I study of the oral platinum agent satraplatin (S) in with capecitabine (C) in patients (pts) with advanced solid malignancies

W. Gradishar, A. Benson, M. Mulcahy, 2008 .

Adjuvant therapy in stage II colon cancer: current approaches.

A. Benson, L. Baddi, 2005, The oncologist.

How often is adjuvant FOLFOX (Adj FOLFOX) discontinued for toxicity among colon cancer patients in the routine care setting?

J. Niland, A. Benson, M. Weiser, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rectal Cancer, Version 2.2015.

James D. Murphy, C. Willett, Yi-Jen Chen, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase 2 study of ABT-751 in patients with refractory metastatic colorectal carcinoma (CRC)

A. Benson, D. Jodrell, H. Kindler, 2005 .

A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer

N. Mattek, A. Benson, H. Lenz, 2018, American journal of clinical oncology.

TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World

P. Lapuerta, A. Benson, V. Joish, 2019, The oncologist.

Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)

D. Neuberg, A. Benson, S. Wadler, 1997, The cancer journal from Scientific American.

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals.

D. Ettinger, R. Carlson, A. Benson, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Colon Cancer , Version 2 . 2018 Featured Updates to the NCCN Guidelines

J. Meyerhardt, James D. Murphy, C. Willett, 2018 .

Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.

D. Neuberg, A. Benson, D. Tormey, 1990, Investigational new drugs.

Phase II study of ionidamine in patients with metastatic breast cancer

D. Neuberg, A. Benson, D. Tormey, 2004, Investigational New Drugs.

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.

B. Yeh, A. Benson, R. Kelley, 2013 .

Rectal cancer clinical practice guidelines in oncology.

A. Benson, L. Saltz, P. Engstrom, 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.

A. Benson, M. Mulcahy, C. Falkson, 2011, Gastrointestinal cancer research : GCR.

2000 U pdate o f A merican S ociety o f C linical O ncology Colorectal C ancer S urveillance G uidelines

Thomas J. Smith, M. Somerfield, N. Petrelli, 2000 .

Bowel perforation and fistula formation in colorectal cancer patients treated on Eastern Cooperative Oncology Group (ECOG) studies E2200 and E3200.

H X Chen, P. Catalano, A. Benson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.

P. Catalano, A. Benson, P. O'dwyer, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)

A. Benson, D. Mahalingam, I. Helenowski, 2023, British Journal of Cancer.

Chapter 5 – Gastrointestinal Malignancies

A. Benson, R. Stein, 2007 .

Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines.

A. Benson, D. Trump, K. Cummings, 1985, Biochemical pharmacology.

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Alan Balch, John Watkins, Massimo Cristofanilli, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

InterAACT: An international multicenter open label randomized phase II advanced anal cancer trial comparing cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus carboplatin (CBDCA) plus weekly paclitaxel (PTX) in patients with inoperable locally recurrent (ILR) or metastatic disease.

J. Welch, A. Benson, D. Cunningham, 2015 .

A feasibility study of dignity therapy in patients with stage IV colorectal cancer actively receiving second-line chemotherapy.

A. Benson, M. Mulcahy, H. Nimeiri, 2014, The Journal of community and supportive oncology.

Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.

J. Koeller, A. Benson, D. Citrin, 1987, Archives of internal medicine.

Phase II Tria l o f Intravenous CI-1042 in Pat ients With Metastat ic Colorecta l Cancer

A. Benson, A. Shields, E. Galanis, 2003 .

S-1: another oral agent for patients with colorectal cancer.

A. Benson, 2013, The Lancet. Oncology.

Phase II ECOG trial of irinotecan/docetaxel with or without cetuximab in metastatic pancreatic cancer: Updated survival and CA19–9 results

J. Berlin, A. Benson, B. Burtness, 2008 .